Tyrosine kinase inhibitor sunitinib relieves systemic and oral antigen-induced anaphylaxes in mice

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 1, 2012, Pages 114-122

  Yamaki, K ^a   Yoshino, S ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

anaphylaxis; food allergy; mast cells; sunitinib; tyrosine kinase inhibitor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MOUSE MAST CELL PROTEASE 1; SERINE PROTEINASE; STEM CELL FACTOR; SUNITINIB; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL GROWTH; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRANULATION; DIARRHEA; DRUG EFFICACY; FOOD ALLERGY; HYPOTHERMIA; IMMUNE RESPONSE; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM TEMPERATURE; SPLEEN CELL; TH1 CELL; TH2 CELL; TREATMENT RESPONSE;

ANAPHYLAXIS; ANIMALS; ANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOSUPPRESSIVE AGENTS; INDOLES; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRROLES; RATS;

EID: 83555172531     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02717.x     Document Type: Article

References (35)

1. Bischoff SC,. Food allergies. Curr Gastroenterol Rep 2006; 8: 374-382. (Pubitemid 44515359)
2. Perdue MH, Masson S, Wershil BK, Galli SJ,. Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis. Correction of the diminished secretory response in genetically mast cell-deficient W/Wv mice by bone marrow transplantation. J Clin Invest 1991; 87: 687-693.
3. Brandt EB, Strait RT, Hershko D, Wang Q, Muntel EE, Scribner TA, et al., Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 2003; 112: 1666-1677. (Pubitemid 38063724)
4. Yu LC, Perdue MH,. Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress. Immunol Rev 2001; 179: 61-73. (Pubitemid 32171274)
5. Lin XP, Magnusson J, Ahlstedt S, Dahlman-Höglund A, Hanson LLA, Magnusson O, et al., Local allergic reaction in food-hypersensitive adults despite a lack of systemic food-specific IgE. J Allergy Clin Immunol 2002; 109: 879-887. (Pubitemid 34499525)
6. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T,. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316: 1622-1626. (Pubitemid 17082588)
7. Abrams TJ, Lee LB, Murray LJ, Pryer NK, Cherrington JM,. SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer. Mol Cancer Ther 2003; 2: 471-478.
8. Mendel DB, Laird AD, Xin X, Louie SG, Christensen JG, Li G, et al., In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res 2003; 9: 327-337. (Pubitemid 36109749)
9. Motzer RJ, Hoosen S, Bello CL, Christensen JG,. Sunitinib malate for the treatment of solid tumours: a review of current clinical data. Expert Opin Investig Drugs 2006; 15: 553-561.
10. Valent P, Spanblöchl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, et al., Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992; 80: 2237-2245.
11. Tsujimura T, Furitsu T, Morimoto M, Kanayama Y, Nomura S, Matsuzawa Y, et al., Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol 1995; 106: 377-385.
12. Yamaki K, Yoshino S,. Comparison of inhibitory activities of zinc oxide ultrafine and fine particulates on IgE-induced mast cell activation. Biometals 2009; 22: 1031-1040.
13. Yamaki K, Alam AH, Hossain MA, Taneda S, Yanagisawa R, Takano H, et al., Effect of rolipram, a phosphodiesterase IV inhibitor, on allergic footpad swelling using various adjuvants in mice. Scand J Immunol 2005; 62: 378-384. (Pubitemid 41565390)
14. Brandt EB, Munitz A, Orekov T, Mingler MK, McBride M, Finkelman FD, et al., Targeting IL-4/IL-13 signaling to alleviate oral allergen-induced diarrhea. J Allergy Clin Immunol 2009; 123: 53-58.
15. 2 pathway in a rat mast cell line. Indications of different pathways for release of arachidonic acid and secretory granules. J Immunol 1995; 154: 5391-5402.
16. Mosmann T,. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63. (Pubitemid 14203433)
17. Bissonnette EY, Chin B, Befus AD,. Isolation and characterization of rat intestinal mucosal mast cells. In:, Gaginella TS, editor. Handbook of methods in gastrointestinal pharmacology. Boca Raton, FL: CRC Press, 1995: 401-418.
18. Jensen BM, Akin C, Gilfillan AM,. Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders. Br J Pharmacol 2008; 154: 1572-1582.
19. Jensen BM, Beaven MA, Iwaki S, Metcalfe DD, Gilfillan AM,. Concurrent inhibition of kit- and FcεRI-mediated signaling: coordinated suppression of mast cell activation. J Pharmacol Exp Ther 2008; 324: 128-138. (Pubitemid 350294172)
20. Hundley TR, Gilfillan AM, Tkaczyk C, Andrade MV, Metcalfe DD, Beaven MA,. Kit and FcεRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 2004; 104: 2410-2417. (Pubitemid 39331841)
21. Krusch M, Salih J, Schlicke M, Baessler T, Kampa KM, Mayer F, et al., The kinase inhibitors sunitinib and sorafenib differentially affect NK cell antitumor reactivity in vitro. J Immunol 2009; 183: 8286-8294.
22. Abouantoun TJ, Castellino RC, MacDonald TJ,. Sunitinib induces PTEN expression and inhibits PDGFR signaling and migration of medulloblastoma cells. J Neurooncol 2011; 101: 215-226.
23. Zar S, Kumar D, Benson MJ,. Review article: food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther 2001; 15: 439-449. (Pubitemid 32242770)
24. Tsujimura Y, Obata K, Mukai K, Shindou H, Yoshida M, Nishikado H, et al., Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 2008; 28: 581-589.
25. Jönsson F, Mancardi DA, Kita Y, Karasuyama H, Iannascoli B, Van Rooijen N, et al., Mouse and human neutrophils induce anaphylaxis. J Clin Invest 2011; 121: 1484-1496.
26. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD,. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 1999; 94: 2333-2342. (Pubitemid 29467681)
27. Metcalfe DD, Mekori JA, Rottem M,. Mast cell ontogeny and apoptosis. Exp Dermatol 1995; 4: 227-230.
28. Akin C, Metcalfe DD,. The biology of Kit in disease and the application of pharmacogenetics. J Allergy Clin Immunol 2004; 114: 13-19. (Pubitemid 39005112)
29. Lam V, Kalesnikoff J, Lee CW, Hernandez-Hansen V, Wilson BS, Oliver JM, et al., IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor. Blood 2003; 102: 1405-1413. (Pubitemid 36988050)
30. Yu LC, Yang PC, Berin MC, Di Leo V, Conrad DH, McKay DM, et al., Enhanced transepithelial antigen transport in intestine of allergic mice is mediated by IgE/CD23 and regulated by interleukin-4. Gastroenterology 2001; 121: 370-381. (Pubitemid 32729384)
31. Lorentz A, Bischoff SC,. Regulation of human intestinal mast cells by stem cell factor and IL-4. Immunol Rev 2001; 179: 57-60. (Pubitemid 32171273)
32. Lorentz A, Wilke M, Sellge G, Worthmann H, Klempnauer J, Manns MP, et al., IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J Immunol 2005; 174: 6751-6756. (Pubitemid 40705637)
33. Perrier C, Thierry AC, Mercenier A, Corthésy B,. Allergen-specific antibody and cytokine responses, mast cell reactivity and intestinal permeability upon oral challenge of sensitized and tolerized mice. Clin Exp Allergy 2010; 40: 153-162.
34. Mao H, Xuan L, Qiang D, Xin Y, Kai-sheng Y,. Inhibitory effects of sunitinib on ovalbumin-induced chronic experimental asthma in mice. Chin Med J 2009; 122: 1061-1066.
35. Eechoute K, van Zonneveld M, van Daele PL, Gerth van Wijk R, Mathijssen RH,. Suppressing effects of sunitinib on allergic rhinitis: previously undefined side effects with therapeutic potential. J Clin Pharmacol 2010; doi:.